Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-01-02 @ 3:25 PM
Study NCT ID:
NCT00315757
Status:
COMPLETED
Last Update Posted:
2013-08-08
First Post:
2006-04-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Human Genome Sciences Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HGS1012-C1055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None